Rossignol, D. P., Wasan, K. M., Choo, E., Yau, E., Wong, N., Rose, J., . . . Lynn, M. (2004). Safety, Pharmacokinetics, Pharmacodynamics, and Plasma Lipoprotein Distribution of Eritoran (E5564) during Continuous Intravenous Infusion into Healthy Volunteers. American Society for Microbiology.
Styl ChicagoRossignol, Daniel P., Kishor M. Wasan, Eugene Choo, Edwin Yau, Nancy Wong, Jeffrey Rose, Jeffrey Moran, a Melvyn Lynn. Safety, Pharmacokinetics, Pharmacodynamics, and Plasma Lipoprotein Distribution of Eritoran (E5564) During Continuous Intravenous Infusion Into Healthy Volunteers. American Society for Microbiology, 2004.
Citace podle MLARossignol, Daniel P., et al. Safety, Pharmacokinetics, Pharmacodynamics, and Plasma Lipoprotein Distribution of Eritoran (E5564) During Continuous Intravenous Infusion Into Healthy Volunteers. American Society for Microbiology, 2004.